Avivagen (VIVX.F) Stock Analysis & Winston Score

Avivagen is a small Canadian life sciences company that makes feed additives for farm animals like chickens, pigs, and cattle. Its main product is OxC-beta Livestock, which is added to animal feed to help keep animals healthy — potentially reducing the need for antibiotics. The company sells to livestock farmers and feed producers, mostly in Asia and parts of North America. Avivagen makes money by selling its OxC-beta product directly to customers in the animal agriculture industry. It is a very small company, still in the early commercial stage, with limited revenue and ongoing losses as it tries to grow its customer base. The global push to reduce antibiotic use in livestock farming is the key growth driver, but the main risk is that the company has struggled to scale sales and depends on continued funding to keep operating.